PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23623323-7	2013	The prepared large size RGD-PEG-LP that targets the TECs via interacting with Integrin alphavbeta3, is a potentially effective and alternate therapeutic strategy for the treatment of DOX resistant tumor cells by utilizing DOX, in cases where Doxil is ineffective.	liposomal doxorubicin	242-247	integrin subunit alpha V	Homo sapiens	78-98